Eddy S Yang Selected Research

Eddy S Yang Research Topics

Disease

72	Neoplasms (Cancer) 05/2024 - 01/2002
16	Breast Neoplasms (Breast Cancer) 07/2023 - 11/2008
12	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 01/2002
11	Head and Neck Neoplasms (Head and Neck Cancer) 10/2023 - 07/2009
9	Squamous Cell Carcinoma of Head and Neck 01/2021 - 06/2011
8	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 09/2012
7	Adenocarcinoma 09/2023 - 03/2015
7	Carcinoma (Carcinomatosis) 01/2020 - 09/2014
6	Carcinogenesis 02/2023 - 07/2013
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020 - 06/2011
5	Triple Negative Breast Neoplasms 08/2021 - 01/2021
4	Body Weight (Weight, Body) 01/2020 - 01/2017
3	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 07/2023 - 12/2015
3	Melanoma (Melanoma, Malignant) 01/2022 - 05/2020
3	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 06/2012
2	Hypoxia (Hypoxemia) 02/2022 - 01/2022
2	Colonic Neoplasms (Colon Cancer) 01/2022 - 08/2010
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 07/2021
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 01/2016
2	Weight Loss (Weight Reduction) 01/2020 - 10/2017
2	Ascites 01/2020 - 12/2016
2	Lung Neoplasms (Lung Cancer) 03/2017 - 03/2015
2	Brain Neoplasms (Brain Tumor) 01/2011 - 05/2009
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 05/2024
1	Gastrointestinal Hemorrhage (Hematochezia) 09/2023
1	Anorexia 01/2022
1	Anemia 01/2022
1	Nausea 01/2022
1	Breast Ductal Carcinoma 01/2022
1	Lobular Carcinoma 01/2022
1	Fatigue 01/2022
1	Vomiting 01/2022
1	Exanthema (Rash) 01/2022

Drug/Important Bio-Agent (IBA)

17	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2021 - 01/2011
12	Proteins (Proteins, Gene)FDA Link 10/2021 - 08/2010
10	DNA (Deoxyribonucleic Acid)IBA 02/2022 - 06/2012
9	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 07/2023 - 01/2011
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2011
8	veliparibIBA 01/2021 - 01/2011
8	Cetuximab (Erbitux)FDA Link 01/2021 - 06/2009
7	Phosphotransferases (Kinase)IBA 01/2022 - 06/2014
5	Gemcitabine FDA Link 05/2024 - 01/2018
5	olaparibIBA 01/2023 - 09/2012
5	ErbB Receptors (EGF Receptor)IBA 01/2022 - 11/2008
5	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 08/2010
4	Trastuzumab (Herceptin)FDA Link 05/2024 - 01/2018
4	(+)-JQ1 compoundIBA 05/2024 - 06/2019
4	RNA (Ribonucleic Acid)IBA 05/2024 - 01/2016
4	Messenger RNA (mRNA)IBA 01/2021 - 04/2015
4	AndrogensIBA 02/2017 - 01/2002
3	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 02/2022 - 01/2011
3	Small Interfering RNA (siRNA)IBA 01/2022 - 06/2011
3	Histones (Histone)IBA 01/2021 - 01/2014
3	prexasertibIBA 01/2021 - 01/2017
3	CateninsIBA 01/2020 - 12/2016
3	Myristoylated Alanine-Rich C Kinase SubstrateIBA 03/2017 - 06/2012
3	Poly (ADP-Ribose) Polymerase-1IBA 01/2017 - 11/2013
3	Vitamin D FDA LinkGeneric 12/2015 - 01/2002
2	CholesterolIBA 05/2024 - 07/2021
2	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2022
2	Monoclonal AntibodiesIBA 04/2023 - 08/2021
2	Hormones (Hormone)IBA 04/2023 - 11/2022
2	EndoglinIBA 04/2023 - 01/2013
2	Everolimus FDA Link 04/2023 - 01/2021
2	Phenobarbital (Luminal)FDA Link 04/2023 - 04/2015
2	Cell-Free Nucleic AcidsIBA 02/2023 - 01/2018
2	fluoromisonidazoleIBA 02/2022 - 01/2022
2	human ERBB2 proteinIBA 01/2022 - 12/2020
2	Immunoconjugates (Immunoconjugate)IBA 08/2021 - 01/2021
2	Maytansine (Maitansine)IBA 08/2021 - 07/2021
2	EnzymesIBA 01/2021 - 11/2013
2	PlatinumIBA 01/2020 - 01/2013
2	Prostate-Specific Antigen (Semenogelase)IBA 01/2019 - 04/2018
2	Niclosamide FDA Link 10/2018 - 12/2016
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 03/2017 - 01/2011
2	Peptides (Polypeptides)IBA 03/2017 - 03/2015
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 07/2004 - 11/2003
2	Cholecalciferol (Vitamin D3)FDA Link 11/2003 - 01/2002
1	pertuzumabIBA 05/2024
1	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 01/2024
1	Granzymes (Granzyme)IBA 01/2024
1	cyclopropapyrroloindoleIBA 01/2024
1	SteroidsIBA 09/2023
1	niraparibIBA 07/2023
1	alovudineIBA 07/2023
1	Letrozole (Femara)FDA LinkGeneric 04/2023
1	carotuximabIBA 04/2023
1	Interleukin-2 (IL2)IBA 02/2022
1	TH 302IBA 01/2022
1	Estrogen ReceptorsIBA 01/2022
1	ruxolitinibIBA 01/2022
1	AfatinibIBA 01/2022
1	N-vinyl-2-pyrrolidinoneIBA 01/2022

Therapy/Procedure

31	Therapeutics 07/2023 - 08/2007
18	Radiotherapy 01/2024 - 06/2011
6	Drug Therapy (Chemotherapy) 04/2023 - 07/2009
5	Precision Medicine 02/2023 - 10/2015
2	Immunotherapy 02/2023 - 01/2022
2	Neoadjuvant Therapy 11/2022 - 01/2018
2	Caloric Restriction 01/2020 - 10/2017